Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maris

Showing results (161-170 of 458) with videos related to

Pageof 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk StratificationHannah G Bender, Meredith S Irwin, Michael D Hogarty, et al.
Pediatric Blood & Cancer|October 27, 2023
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to <sup>131</sup> I-MIBG in patients with relapsed/refractory neuroblastomaVandana Batra, Ajami Gikandi, Bruce Pawel, et al.
Oncogene|April 15, 2005
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastomaPeter S White, Patricia M Thompson, Takahiro Gotoh, et al.
Genome Research|January 15, 2009
Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidyEdward F Attiyeh, Sharon J Diskin, Marc A Attiyeh, et al.
Pediatric Blood & Cancer|December 19, 2007
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing programRichard Lock, Hernan Carol, Peter J Houghton, et al.
Scientific Data|March 29, 2017
Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastomaKatherine K Matthay, Gregory Yanik, Julia Messina, et al.
IEEE Transactions on Medical Imaging|January 11, 2021
Quantitative Evaluation of an Automated Cone-Based Breast Ultrasound Scanner for MRI-3D US Image FusionAnton V Nikolaev, Leon de Jong, Gert Weijers, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Molecular analysis of the region of distal 1p commonly deleted in neuroblastomaP S White, J M Maris, E P Sulman, et al.
Scientific Data|December 6, 2017
Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.
Pageof 46

Showing results (161-170 of 458) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk StratificationHannah G Bender, Meredith S Irwin, Michael D Hogarty, et al.
Pediatric Blood & Cancer|October 27, 2023
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to <sup>131</sup> I-MIBG in patients with relapsed/refractory neuroblastomaVandana Batra, Ajami Gikandi, Bruce Pawel, et al.
Oncogene|April 15, 2005
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastomaPeter S White, Patricia M Thompson, Takahiro Gotoh, et al.
Genome Research|January 15, 2009
Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidyEdward F Attiyeh, Sharon J Diskin, Marc A Attiyeh, et al.
Pediatric Blood & Cancer|December 19, 2007
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing programRichard Lock, Hernan Carol, Peter J Houghton, et al.
Scientific Data|March 29, 2017
Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastomaKatherine K Matthay, Gregory Yanik, Julia Messina, et al.
IEEE Transactions on Medical Imaging|January 11, 2021
Quantitative Evaluation of an Automated Cone-Based Breast Ultrasound Scanner for MRI-3D US Image FusionAnton V Nikolaev, Leon de Jong, Gert Weijers, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Molecular analysis of the region of distal 1p commonly deleted in neuroblastomaP S White, J M Maris, E P Sulman, et al.
Scientific Data|December 6, 2017
Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.
Pageof 46